All from
one expert
NGS partner

“Large-scale genomic information is accelerating scientific progress in cancer, diabetes, psychiatric disorders and many other diseases. Storing, analyzing and managing these data is becoming a critical challenge for biomedical researchers.“


Eric Lander, President and Director of the Broad Institute*

Targeted NGS panels and optimized analysis and interpretation tools

NGS can be challenging – overcome the bottlenecks you face with the help of our single kit solution. We’ve combined the precision of our QIAseq DNA Panels with intuitive bioinformatics tools to create a single unified solution so you can detect low-frequency variants and analyze your NGS data with confidence. QIAseq DNA panels now include subscription licenses for CLC Genomics Workbench and QIAGEN Clinical Insight (QCI)-Interpret for QIAseq software, so you can make the leap from generating data to accumulating insights with greater ease and speed. Learn more here.

Superior solutions for every step of the workflow

Targeted Sequencing
Data Analysis
Variant Interpretation

Available QIAseq DNA Panels

Cancer Panels:

Breast Cancer
Colorectal Cancer
Myeloid Neoplasms
Lung Cancer
Solid Tumor
BRCA1 and BRCA2 Plus
Comprehensive Cancer
Tumor Mutational Burden

Hereditary Disease Panels:

Inherited Disease

Learn more here

Insight makes the difference

QIAseq DNA Panel kits don’t just deliver superior sequencing coverage and a faster workflow — they also provide the tools you need to gain knowledge from results, using QCI-Interpret for QIAseq software. Supporting more than 1000 laboratories and professionals worldwide, the cloud-based QCI platform provides all the capabilities required to transform complex NGS data into insights, in an easy-to-understand sample report.

• Discover novel findings more quickly
• Access comprehensive variant information
• Use tailored workflows for multiple applications

Check out an example report here.

Try our integrated solution

I hereby give QIAGEN the consent to contact me via email and phone (subject to the contact information provided above) with further contests, special offers and product information.*

* Subject to your consent given above, QIAGEN may use your personal information for internal business and marketing purposes. The information will not be sold to any third party. QIAGEN may transfer your personal information to our CRM system (hosted by, Inc. and Oracle Corp.) solely for the purposes of data hosting, phone calls and QIAGEN email distribution. You may unsubscribe at any time. Your data will be processed in compliance with applicable privacy laws including the EU General Data Protection Regulation All information you provide in this site will be governed by our Privacy Policy.

Access more resources here

Want to see how our NGS and analysis tools could work in your own lab? Check out these webinars to discover how our experts seamlessly go from sequencing to insights.

Part 1: Advice prior to starting a sequencing project

Speaker: Jonathan M. Shaffer, M.B.A., Ph.D.,  Associate Director, NGS Assay Technologies – QIAGEN

Part 2: Seamless workflows using QIAGEN’s variant detection and interpretation

Speaker: Prakriti Mudvari, Ph.D., Senior Bioinformatics Scientist – QIAGEN

*Eric Lander, president and director of the Broad Institute (2015, June 24) Researchers to use Google cloud to aid in genome analysis. [Press release]. Retrieved from

The products mentioned here are intended for molecular biology applications. These products are not intended for the diagnosis, prevention, or treatment of a disease.

Thank you for your interest in QIAGEN’s targeted NGS panels and optimized analysis tools. You will be contacted shortly by one of our application scientists.